New research: GLP-1 receptor agonists may support nicotine cessation
New research presented May 17 at the American Psychiatric Association’s Annual Meeting shows that GLP-1 receptor agonists may be able to help cigarette smokers reduce weight gain while they are quitting.
Obesity drugs found to improve emotional well-being as well as physical health
A major new meta-analysis from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has found that glucagon-like peptide 1 receptor agonists (GLP1-RAs)—a class of medications used to treat obesity and diabetes—may also offer benefits for emotional well-being in overweight users.
GLP-1 Drugs Appear To Lower Cancer Risk
By Dennis Thompson HealthDay ReporterMONDAY, May 19, 2025 (HealthDay News) — Cutting-edge GLP-1 weight-loss drugs appear to help lower cancer risk…